Related Experiment Video
Updated: May 28, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Machine Learning Risk Stratification Approach Using Patient-Reported Outcomes for Forecasting Unplanned Health Care
Akina Natori1, Jerry R Bonnell2, Vasileios Stathias3,4
1Division of Medical Oncology, Department of Medicine, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Coral Gables, FL.
Purpose:
Effective risk stratification in cancer survivorship requires handling longitudinal data characterized by multimodal inputs, irregular follow-up, and recurrent clinical events. This study evaluated the incremental value of integrating patient-reported outcomes (PROs) with electronic health record (EHR) data and identified optimal windowing strategies for machine learning-based prediction of adverse survivorship outcomes.
Patients And Methods:
This study used a cohort of 25,592 cancer survivors followed for 36 months. Data from four domains were integrated: baseline measures, treatments, PROs, and health care utilization (emergency room visits and hospitalizations). Two classification models, LASSO and CATBOOST, were applied across modality combinations and five temporal representations of patient history: static early-phase (0-6 months), cumulative history, sliding windows (4- and 12-month), and a most-recent baseline. Performance was evaluated for predicting monthly health care utilization and patient-reported symptom burden using average precision (AP). SHapley Additive exPlanations (SHAP) analysis identified key predictors and characterized their evolving influence.
Results:
For health care utilization, CATBOOST models trained on the full multimodal data set with time-windowed predictors achieved strong discrimination (AP = 0.207), outperforming static baselines by 27%. SHAP analyses emphasized dynamic contributions from recent utilization and treatment toxicity. For symptom burden, PRO integration was crucial, nearly doubling clinical-only performance (AP = 0.132 v 0.071), with longer historical context improving characterization of progressive functional decline and symptom severity. Flagging the top 10% of patients by predicted risk captured 51.7% of health care utilizations and 46.7% of symptom burden events.
Conclusion:
Adverse survivorship risk is dynamic and outcome-specific: acute health care utilization is best predicted by recent clinical momentum, while longitudinal patient-reported trends drive symptom burden. Implementing decoupled, dynamic windows provides a flexible framework for risk stratification and risk prediction beyond standard clinical heuristics, facilitating proactive, precision-based survivorship care.
Related Concept Videos
Cancer Survival Analysis
Kaplan-Meier Approach
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Actuarial Approach
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Comparing the Survival Analysis of Two or More Groups
